| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population.
|
J Acquir Immune Defic Syndr
|
2007
|
3.38
|
|
2
|
Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy.
|
AIDS
|
2006
|
2.19
|
|
3
|
Factors associated with adherence to infectious diseases advice in two intensive care units.
|
J Antimicrob Chemother
|
2006
|
2.04
|
|
4
|
The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
|
Addiction
|
2008
|
1.76
|
|
5
|
Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment.
|
Clin Infect Dis
|
2009
|
1.65
|
|
6
|
Impact of antiretroviral treatment on progression of hepatic fibrosis in HIV/hepatitis C virus co-infected patients.
|
AIDS
|
2004
|
1.64
|
|
7
|
Bacteremia in patients receiving TNF-alpha antagonists--a prospective multicenter study.
|
J Infect
|
2013
|
1.52
|
|
8
|
Pharmacogenetics of toxicity, plasma trough concentration and treatment outcome with nevirapine-containing regimen in anti-retroviral-naïve HIV-infected adults: an exploratory study of the TRIANON ANRS 081 trial.
|
Basic Clin Pharmacol Toxicol
|
2011
|
1.42
|
|
9
|
Scalp eschar and neck lymphadenopathy caused by Bartonella henselae after Tick Bite.
|
Clin Infect Dis
|
2010
|
1.40
|
|
10
|
Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.
|
J Antimicrob Chemother
|
2009
|
1.39
|
|
11
|
[Value of PCR amplification from formalin-fixed paraffin-embedded tissues in the diagnosis of Mycobacterium tuberculosis infection].
|
Ann Pathol
|
2003
|
1.36
|
|
12
|
Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study.
|
HIV Clin Trials
|
2003
|
1.36
|
|
13
|
Risk factors of chronic kidney disease in HIV-infected patients.
|
Clin J Am Soc Nephrol
|
2011
|
1.21
|
|
14
|
Health related quality of life among both current and former injection drug users who are HIV-infected.
|
Drug Alcohol Depend
|
2006
|
1.18
|
|
15
|
Protease inhibitor resistance analysis in the MONARK trial comparing first-line lopinavir-ritonavir monotherapy to lopinavir-ritonavir plus zidovudine and lamivudine triple therapy.
|
Antimicrob Agents Chemother
|
2009
|
1.17
|
|
16
|
Severe pneumonia during primary infection with an atypical strain of Toxoplasma gondii in an immunocompetent young man.
|
J Infect
|
2005
|
1.16
|
|
17
|
PharmAdapt: a randomized prospective study to evaluate the benefit of therapeutic monitoring of protease inhibitors: 12 week results.
|
AIDS
|
2002
|
1.15
|
|
18
|
Self-reported fatigue and depressive symptoms as main indicators of the quality of life (QOL) of patients living with HIV and Hepatitis C: implications for clinical management and future research.
|
HIV Clin Trials
|
2007
|
1.14
|
|
19
|
Influence of child care on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae.
|
Pediatr Infect Dis J
|
2003
|
1.14
|
|
20
|
Haemophilus influenzae carriage in children attending French day care centers: a molecular epidemiological study.
|
J Clin Microbiol
|
2003
|
1.05
|
|
21
|
Uncontrolled viral replication as a risk factor for non-AIDS severe clinical events in HIV-infected patients on long-term antiretroviral therapy: APROCO/COPILOTE (ANRS CO8) cohort study.
|
J Acquir Immune Defic Syndr
|
2009
|
1.00
|
|
22
|
Can high central nervous system penetrating antiretroviral regimens protect against the onset of HIV-associated neurocognitive disorders?
|
AIDS
|
2014
|
0.99
|
|
23
|
Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control study.
|
Arthritis Res Ther
|
2010
|
0.96
|
|
24
|
[Tuberculosis: a rare and misleading etiology of tongue's ulcer].
|
Ann Pathol
|
2003
|
0.95
|
|
25
|
Trends in nasopharyngeal carriage of Streptococcus pneumoniae among children attending daycare centers in southeastern France from 1999 to 2006.
|
Pediatr Infect Dis J
|
2008
|
0.95
|
|
26
|
Simplification therapy with once-daily emtricitabine, didanosine, and efavirenz in HIV-1-infected adults with viral suppression receiving a protease inhibitor-based regimen: a randomized trial.
|
J Infect Dis
|
2005
|
0.93
|
|
27
|
Evaluation of e-Bug, an educational pack, teaching about prudent antibiotic use and hygiene, in the Czech Republic, France and England.
|
J Antimicrob Chemother
|
2010
|
0.93
|
|
28
|
A randomized trial to evaluate continuation versus discontinuation of lamivudine in individuals failing a lamivudine-containing regimen: the COLATE trial.
|
Antivir Ther
|
2006
|
0.90
|
|
29
|
Long-term treatment with lopinavir-ritonavir induces a reduction in peripheral adipose depots in mice.
|
Antimicrob Agents Chemother
|
2006
|
0.90
|
|
30
|
Adding HCV treatment to HIV treatment in HIV-HCV coinfected patients: the impact on the different dimensions of fatigue and self-reported side effects.
|
J Pain Symptom Manage
|
2007
|
0.84
|
|
31
|
Lopinavir/ritonavir combination and total/HDL cholesterol ratio.
|
J Infect
|
2005
|
0.84
|
|
32
|
The role of lipopolysaccharide as a marker of immune activation in HIV-1 infected patients: a systematic literature review.
|
Virol J
|
2012
|
0.83
|
|
33
|
Hand edema and acrocyanosis: "puffy hand syndrome".
|
Arch Dermatol
|
2006
|
0.83
|
|
34
|
Incidence and risk factors of Legionella pneumophila pneumonia during anti-tumor necrosis factor therapy: a prospective French study.
|
Chest
|
2013
|
0.83
|
|
35
|
Sensitive enzyme immunoassay for measuring plasma and intracellular nevirapine levels in human immunodeficiency virus-infected patients.
|
Antimicrob Agents Chemother
|
2004
|
0.82
|
|
36
|
Boosted protease inhibitor-based or nonnucleoside reverse transcriptase-based HAART: is there a best choice for antiretroviral-naive HIV-1 infected patients?
|
AIDS Rev
|
2008
|
0.82
|
|
37
|
Kinetics of disappearance of resistance mutations and reappearance of wild-type during structured treatment interruptions.
|
AIDS
|
2003
|
0.82
|
|
38
|
The e-Bug project in France.
|
J Antimicrob Chemother
|
2011
|
0.82
|
|
39
|
Early CD4(+) T cell recovery in human immunodeficiency virus-infected patients receiving effective therapy is related to a down-regulation of apoptosis and not to proliferation.
|
J Infect Dis
|
2002
|
0.82
|
|
40
|
The value of polymerase chain reaction detection of Mycobacterium tuberculosis in granulomas isolated by laser capture microdissection.
|
Pathology
|
2004
|
0.81
|
|
41
|
Sarcoid-like lesions associated with the immune restoration inflammatory syndrome in AIDS: absence of polymerase chain reaction detection of Mycobacterium tuberculosis in granulomas isolated by laser capture microdissection.
|
Virchows Arch
|
2006
|
0.81
|
|
42
|
Pseudomonas aeruginosa ecthyma gangrenosum and facial cellulitis complicating carbimazole-induced agranulocytosis.
|
Arch Dermatol
|
2006
|
0.81
|
|
43
|
Indinavir plasma concentration and adherence score are codeterminant of early virologic response in HIV-infected patients of the APROCO cohort.
|
Ther Drug Monit
|
2005
|
0.81
|
|
44
|
Randomized placebo-controlled study of the safety, tolerability, antiviral activity, and pharmacokinetics of 10-day monotherapy with BMS-986001, a novel HIV NRTI, in treatment-experienced HIV-1-infected subjects.
|
J Acquir Immune Defic Syndr
|
2013
|
0.81
|
|
45
|
Long-term evolution and determinants of renal function in HIV-infected patients who began receiving combination antiretroviral therapy in 1997-1999, ANRS CO8 APROCO-COPILOTE.
|
Clin Infect Dis
|
2009
|
0.80
|
|
46
|
Baseline CD4 cell count and outcome of pegylated interferon plus ribavirin therapy in HIV/hepatitis C virus-coinfected patients.
|
J Acquir Immune Defic Syndr
|
2008
|
0.79
|
|
47
|
Concomitant Staphylococcus aureus bacteriuria is associated with complicated S. aureus bacteremia.
|
J Infect
|
2009
|
0.78
|
|
48
|
HIV-1 infection and first line ART induced differential responses in mitochondria from blood lymphocytes and monocytes: the ANRS EP45 "Aging" study.
|
PLoS One
|
2012
|
0.78
|
|
49
|
Relevance of lipopolysaccharide levels in HIV-associated neurocognitive impairment: the Neuradapt study.
|
J Neurovirol
|
2013
|
0.78
|
|
50
|
An enzyme immunoassay for the quantification of plasma and intracellular lopinavir in HIV-infected patients.
|
J Immunol Methods
|
2004
|
0.78
|
|
51
|
HIV protease inhibitors do not cause the accumulation of prelamin A in PBMCs from patients receiving first line therapy: the ANRS EP45 "aging" study.
|
PLoS One
|
2012
|
0.78
|
|
52
|
Self-reported side effects in buprenorphine and methadone patients receiving antiretroviral therapy: results from the MANIF 2000 cohort study.
|
Addiction
|
2010
|
0.78
|
|
53
|
In vivo comparative pharmacokinetics and pharmacodynamics of moxifloxacin and levofloxacin in human neutrophils.
|
Clin Drug Investig
|
2005
|
0.78
|
|
54
|
Withdrawal symptoms as a predictor of mortality in patients HIV-infected through drug use and receiving highly active antiretroviral therapy (HAART).
|
Drug Alcohol Depend
|
2008
|
0.78
|
|
55
|
HIV-1 and persistent clinical latency, TAR element analysis and improved method for in vitro viral reactivation.
|
J Clin Virol
|
2007
|
0.77
|
|
56
|
Fluoroquinolone prescriptions in a teaching hospital: a prospective audit.
|
Scand J Infect Dis
|
2007
|
0.77
|
|
57
|
Effect of lopinavir/ritonavir monotherapy on quality of life and self-reported symptoms among antiretroviral-naive patients: results of the MONARK trial.
|
Antivir Ther
|
2008
|
0.77
|
|
58
|
Impaired anger control as an underappreciated side effect of treatments for chronic HCV infection in HIV-HCV coinfected patients.
|
J Clin Gastroenterol
|
2008
|
0.77
|
|
59
|
Yeast cells as a tool for analysis of HIV-1 protease susceptibility to protease inhibitors, a comparative study.
|
J Virol Methods
|
2013
|
0.77
|
|
60
|
["Antibiotics only when necessary" campaign in the Alpes-Maritimes district: no negative impact on invasive infections in children in the community 1998-2003].
|
Presse Med
|
2008
|
0.77
|
|
61
|
Infliximab and human immunodeficiency virus infection: Viral load reduction and CD4+ T-cell loss related to apoptosis.
|
Arch Intern Med
|
2006
|
0.77
|
|
62
|
Factors associated with liver biopsy performance in HCV-HIV coinfected injecting drug users with HCV viremia: results from a five-year longitudinal assessment.
|
J Urban Health
|
2004
|
0.76
|
|
63
|
Apoptosis of naive CD4+ T-cells from HIV-infected patients with poor immune response to HAART is enhanced in vitro by steroid.
|
J Infect
|
2004
|
0.76
|
|
64
|
First-line cART regimen impacts the course of CD8+ T-cell counts in HIV-infected patients that achieve sustained undetectable viral load.
|
Medicine (Baltimore)
|
2016
|
0.75
|
|
65
|
Determination of ddATP levels in human immunodeficiency virus-infected patients treated with dideoxyinosine.
|
Antimicrob Agents Chemother
|
2004
|
0.75
|
|
66
|
Influenza vaccination: impact of an intervention campaign targeting hospital staff.
|
Infect Control Hosp Epidemiol
|
2006
|
0.75
|
|
67
|
[Antiretroviral treatments-related lipodystrophy syndrome: clinico-pathological findings].
|
Ann Pathol
|
2005
|
0.75
|
|
68
|
[An oral infection not to be underestimated: actinomycosis. A study of 4 cases with extensive bone necrosis].
|
Ann Pathol
|
2003
|
0.75
|
|
69
|
Tipranavir in highly antiretroviral treatment-experienced patients: Results from a French prospective cohort.
|
Scand J Infect Dis
|
2011
|
0.75
|
|
70
|
Cutaneous complications of direct intra-arterial injections in drug addicts.
|
Acta Derm Venereol
|
2005
|
0.75
|
|
71
|
[Peer visits to community-based general practitioners and pediatricians as part of the "Antibiotics only when necessary" campaign in the Alpes-Maritimes district. Methodology, feasibility, and interest].
|
Presse Med
|
2006
|
0.75
|
|
72
|
[Escherichia coli bacteremic urinary tract infections. Clinical aspects and pronostic factors].
|
Presse Med
|
2004
|
0.75
|
|
73
|
[Registry of liver biopsies from hepatitis C infected patients in the Alpes-Maritimes (France). Results from the first 2 years].
|
Gastroenterol Clin Biol
|
2002
|
0.75
|
|
74
|
What do HIV-infected patients become after an opportunistic infection?
|
AIDS
|
2006
|
0.75
|
|
75
|
Neuromeningeal tuberculosis in a patient with rheumatoid arthritis previously exposed to ineffective etanercept therapy and revealed by infliximab.
|
J Rheumatol
|
2010
|
0.75
|
|
76
|
Apoptosis and proliferation kinetics of T cells in patients having experienced antiretroviral treatment interruptions.
|
J Antimicrob Chemother
|
2003
|
0.75
|
|
77
|
Long-term virological outcome in patients infected with multi-nucleoside analogue-resistant HIV-1.
|
Antivir Ther
|
2002
|
0.75
|
|
78
|
Epidemiology of autoimmune and inflammatory diseases in a French Nationwide HIV cohort.
|
AIDS
|
2017
|
0.75
|